Introduction: Recent studies indicated tumors may be comprised of heterogeneous molecular subtypes and incongruent molecular portraits may emerge if di erent areas of the tumor are sampled. This study explored the impact of intra- tumoral heterogeneity in terms of activation/phosphorylation of FDA approved drug targets and downstream kinase substrates. Material and methods: Two independent sets of liver metastases from colorectal cancer were used to evaluate protein kinase-driven signaling networks within di erent areas using laser capture microdissection and reverse phase protein array. Results: Unsupervised hierarchical clustering analysis indicated that the signaling architecture and activation of the MAPK and AKT-mTOR pathways were consistently maintained within di erent regions of the same biopsy. Intra-patient variability of the MAPK and AKT-mTOR pathway were <1.06 fold change, while inter-patients variability reached fold change values of 5.01. Conclusions: Protein pathway activation mapping of enriched tumor cells obtained from di erent regions of the same tumor indicated consistency and robustness independent of the region sampled. This suggests a dominant protein pathway network may be activated in a high percentage of the tumor cell population. Given the genomic intra-tumoral variability, our data suggest that protein/phosphoprotein signaling measurements should be integrated with genomic analysis for precision medicine based analysis.

Parasido, E., Silvestri, A., Canzonieri, V., Belluco, C., Diodoro, M., Milione, M., Melotti, F., De Maria Marchiano, R., Liotta, L., Petricoin, E., Pierobon, M., Protein drug target activation homogeneity in the face of intra- tumor heterogeneity: implications for precision medicine, <<ONCOTARGET>>, 2017; (8 (30)): 48534-48544. [doi:10.18632/oncotarget.14019] [http://hdl.handle.net/10807/111258]

Protein drug target activation homogeneity in the face of intra- tumor heterogeneity: implications for precision medicine

De Maria Marchiano, Ruggero;
2017

Abstract

Introduction: Recent studies indicated tumors may be comprised of heterogeneous molecular subtypes and incongruent molecular portraits may emerge if di erent areas of the tumor are sampled. This study explored the impact of intra- tumoral heterogeneity in terms of activation/phosphorylation of FDA approved drug targets and downstream kinase substrates. Material and methods: Two independent sets of liver metastases from colorectal cancer were used to evaluate protein kinase-driven signaling networks within di erent areas using laser capture microdissection and reverse phase protein array. Results: Unsupervised hierarchical clustering analysis indicated that the signaling architecture and activation of the MAPK and AKT-mTOR pathways were consistently maintained within di erent regions of the same biopsy. Intra-patient variability of the MAPK and AKT-mTOR pathway were <1.06 fold change, while inter-patients variability reached fold change values of 5.01. Conclusions: Protein pathway activation mapping of enriched tumor cells obtained from di erent regions of the same tumor indicated consistency and robustness independent of the region sampled. This suggests a dominant protein pathway network may be activated in a high percentage of the tumor cell population. Given the genomic intra-tumoral variability, our data suggest that protein/phosphoprotein signaling measurements should be integrated with genomic analysis for precision medicine based analysis.
2017
Inglese
Parasido, E., Silvestri, A., Canzonieri, V., Belluco, C., Diodoro, M., Milione, M., Melotti, F., De Maria Marchiano, R., Liotta, L., Petricoin, E., Pierobon, M., Protein drug target activation homogeneity in the face of intra- tumor heterogeneity: implications for precision medicine, <<ONCOTARGET>>, 2017; (8 (30)): 48534-48544. [doi:10.18632/oncotarget.14019] [http://hdl.handle.net/10807/111258]
File in questo prodotto:
File Dimensione Formato  
Protein drug target activation.pdf

accesso aperto

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 4.26 MB
Formato Adobe PDF
4.26 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/111258
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 6
social impact